Restatement of previously issued financial statements (unaudited) (Details) - USD ($) |
Jun. 30, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Sep. 30, 2019 |
Jun. 30, 2019 |
Mar. 31, 2019 |
---|---|---|---|---|---|---|
Profit Share liability | $ 2,555,133 | $ 2,305,308 | $ 2,328,845 | |||
Secured note payable | 271,686 | 271,686 | 271,686 | |||
Unsecured convertible notes and warrants | 10,874,645 | 9,894,284 | 7,911,898 | |||
Total liabilities | 17,805,331 | 20,579,897 | 18,146,889 | |||
Stockholders' deficit | ||||||
Additional paid-in capital | 56,234,920 | 50,202,478 | 48,708,085 | |||
Accumulated deficit | (65,631,723) | (63,484,106) | (57,658,484) | |||
Total liabilities and stockholders' deficit | $ 8,497,774 | $ 7,376,365 | $ 9,273,238 | |||
As restated [Member] | ||||||
Profit Share liability | $ 2,210,230 | $ 2,097,655 | $ 1,991,940 | |||
Secured note payable | 271,686 | |||||
Unsecured convertible notes and warrants | 7,413,593 | 6,915,288 | 6,422,400 | |||
Total liabilities | 17,048,634 | 16,571,960 | 14,811,797 | |||
Stockholders' deficit | ||||||
Additional paid-in capital | 48,294,413 | 48,158,130 | 46,198,194 | |||
Accumulated deficit | (56,170,208) | (55,366,550) | (52,619,977) | |||
Total liabilities and stockholders' deficit | 9,249,586 | 9,440,250 | 8,466,260 | |||
Total stockholders' deficit | (7,799,048) | (7,131,710) | (6,345,537) | |||
Adjustment [Member] | ||||||
Profit Share liability | 2,210,230 | 2,097,655 | 1,991,940 | |||
Secured note payable | 0 | |||||
Unsecured convertible notes and warrants | (2,339,289) | (2,179,831) | (1,981,568) | |||
Total liabilities | (129,059) | (82,176) | 10,372 | |||
Stockholders' deficit | ||||||
Additional paid-in capital | 3,412,204 | 3,412,204 | 3,412,204 | |||
Accumulated deficit | (3,283,145) | (3,330,028) | (3,422,576) | |||
Total liabilities and stockholders' deficit | 0 | 0 | 0 | |||
Total stockholders' deficit | 129,059 | 82,176 | (10,372) | |||
As previously reported [Member] | ||||||
Profit Share liability | 0 | 0 | 0 | |||
Secured note payable | 271,686 | |||||
Unsecured convertible notes and warrants | 9,752,882 | 9,095,119 | 8,403,968 | |||
Total liabilities | 17,177,693 | 16,654,136 | 14,801,425 | |||
Stockholders' deficit | ||||||
Additional paid-in capital | 44,882,209 | 44,745,926 | 42,785,990 | |||
Accumulated deficit | (52,887,063) | (52,036,522) | (49,197,401) | |||
Total liabilities and stockholders' deficit | 9,249,586 | 9,440,250 | 8,466,260 | |||
Total stockholders' deficit | $ (7,928,107) | $ (7,213,886) | $ (6,335,165) |
X | ||||||||||
- Definition Amount of gain (loss) from the increase (decrease) in fair value of foreign currency derivatives and nonderivative instruments designated as fair value hedging instruments which were recognized in earnings, net of offsets by the gain (loss) on the hedged No definition available.
|
X | ||||||||||
- Definition Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|